Real-world (RW) clinical outcomes of patients (pts) with myelofibrosis (MF) treated with ruxolitinib (RUX): evidence from a multinational medical record reviewF. H. Heidel,F. Passamonti,R. C. Parikh,D. Tang, B. J. Lahue, J. A. Nadal, K. L. Davis,M. Ajmera, A. Kee,P. AbrahamONCOLOGY RESEARCH AND TREATMENT（2021）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
